Are Betavert (betahistine) and Vertin (betahistine) the same?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Betavert and Vertin: Same Medication with Different Brand Names

Yes, Betavert and Vertin are the same medication - both are brand names for betahistine, which is used primarily for vertigo management in conditions like Ménière's disease. 1

Pharmacological Profile

  • Betahistine is a weak histamine H1 receptor agonist and a more potent histamine H3 receptor antagonist 2
  • The standard dosage for vertigo treatment is 48 mg daily, typically divided into three doses 1
  • Treatment duration should be at least 3 months to properly evaluate efficacy 1

Clinical Efficacy

  • The American Academy of Otolaryngology-Head and Neck Surgery does not make a definitive recommendation for betahistine use in controlling Ménière's disease symptoms due to conflicting evidence 1, 3
  • The BEMED trial, considered high-quality evidence, showed no significant difference between betahistine (at both standard 48 mg/day and high 144 mg/day doses) and placebo in reducing vertigo attacks over a 9-month treatment period 4, 3
  • Betahistine shows maximum benefit in different types of peripheral vertigo, particularly in Ménière's disease when used at 48 mg daily for 3 months 5

Safety Profile and Precautions

  • Common side effects include headache, balance disorder, nausea, nasopharyngitis, feeling hot, eye irritation, palpitations, and upper gastrointestinal symptoms 3, 1
  • Betahistine is completely contraindicated in patients with pheochromocytoma 6, 1
  • The medication should be used with caution in patients with asthma and history of peptic ulcer disease 3, 6

Monitoring and Treatment Duration

  • Patients should be reassessed regularly for symptom improvement and to monitor for medication intolerance or side effects 3, 1
  • Most betahistine studies covered only a 2-12 week treatment period, though the BEMED trial extended to 9 months 3
  • If there is no improvement in vertigo symptoms after 6-9 months of treatment, continued betahistine therapy is unlikely to be beneficial 1

Alternative Treatments for Acute Vertigo

  • For acute vertigo episodes, medications with direct antiemetic and anti-vertigo effects like prochlorperazine are preferred over betahistine 4
  • Prochlorperazine is more effective for immediate symptom control during acute vertigo attacks 4

Common Pitfalls to Avoid

  • Continuing betahistine indefinitely without reassessing its effectiveness 4, 1
  • Not considering the potential contraindications, particularly in patients with pheochromocytoma 6
  • Failing to distinguish between different causes of vertigo which may respond differently to treatment 4

References

Guideline

Betahistine Treatment for Vertigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Betahistine in the treatment of Ménière's disease.

Neuropsychiatric disease and treatment, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Acute Vertigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Betahistine Contraindications and Precautions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.